000 | 01694 a2200457 4500 | ||
---|---|---|---|
005 | 20250513133635.0 | ||
264 | 0 | _c19980206 | |
008 | 199802s 0 0 eng d | ||
022 | _a1044-9523 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChang, Y C | |
245 | 0 | 0 |
_amdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. _h[electronic resource] |
260 |
_bCell growth & differentiation : the molecular biology journal of the American Association for Cancer Research _cJan 1998 |
||
300 |
_a79-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCysteine Endopeptidases _xmetabolism |
650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrolysis |
650 | 0 | 4 |
_aLeupeptins _xpharmacology |
650 | 0 | 4 |
_aMultienzyme Complexes _xmetabolism |
650 | 0 | 4 | _aNuclear Proteins |
650 | 0 | 4 | _aProteasome Endopeptidase Complex |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
650 | 0 | 4 | _aProto-Oncogene Proteins c-bcl-2 |
650 | 0 | 4 | _aProto-Oncogene Proteins c-mdm2 |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
650 | 0 | 4 |
_aUbiquitins _xmetabolism |
650 | 0 | 4 | _abcl-2-Associated X Protein |
700 | 1 | _aLee, Y S | |
700 | 1 | _aTejima, T | |
700 | 1 | _aTanaka, K | |
700 | 1 | _aOmura, S | |
700 | 1 | _aHeintz, N H | |
700 | 1 | _aMitsui, Y | |
700 | 1 | _aMagae, J | |
773 | 0 |
_tCell growth & differentiation : the molecular biology journal of the American Association for Cancer Research _gvol. 9 _gno. 1 _gp. 79-84 |
|
999 |
_c9407691 _d9407691 |